Psych Vivas · Foundations — neuroimaging in psychiatry
Neuroimaging in psychiatry — structured clinical viva
Fellowship viva on clinical imaging decisions, modality critique, landmark evidence, and communication.
On this page & tools
Target exams
Interpretation
Reveal interpretation
Case split. Young FEP without red flags: clinical diagnosis; structural MRI may be considered per local early-psychosis policy and residual uncertainty, but fMRI/PET are not diagnostic confirmations. Older patient with focal signs: urgent structural imaging and medical pathway. [6][7]
BOLD. Haemodynamic proxy; reverse inference invalid as sole mental-state decoder. [1][2]
PET occupancy. Supports excess dopaminergic tone models and version III teaching; not required before first antipsychotic. [3][4]
Group structure. ENIGMA and earlier meta-analyses show population differences; not personal tests. [5]
Counselling. Purpose, limits, incidental findings; normal scan does not mean non-biological illness; hope and treatment plan. [7]
Key points
References
- [1]Logothetis NK, Pauls J, Augath M, et al. Neurophysiological investigation of the basis of the fMRI signal Nature, 2001.PMID 11449264
- [2]Logothetis NK What we can do and what we cannot do with fMRI Nature, 2008.PMID 18548064
- [3]Abi-Dargham A, Rodenhiser J, Printz D, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia Proc Natl Acad Sci U S A, 2000.PMID 10884434
- [4]Howes OD, Kapur S The dopamine hypothesis of schizophrenia: version III--the final common pathway Schizophr Bull, 2009.PMID 19325164
- [5]van Erp TG, Hibar DP, Rasmussen JM, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium Mol Psychiatry, 2016.PMID 26283641
- [6]Freudenreich O, Schulz SC, Goff DC Initial medical work-up of first-episode psychosis: a conceptual review Early Interv Psychiatry, 2009.PMID 21352170
- [7]First MB, Drevets WC, Carter C, et al. Clinical Applications of Neuroimaging in Psychiatric Disorders Am J Psychiatry, 2018.PMID 30173550